BOIRON Logo

BOIRON

Global manufacturer of homeopathic medicines for pain relief and flu-like symptoms, sold worldwide.

BOI | PA

Overview

Corporate Details

ISIN(s):
FR0000061129
LEI:
9695000UMPNY21KKDO98
Country:
France
Address:
2 AVENUE DE L'OUEST LYONNAIS, 69510 MESSIMY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Boiron is a global manufacturer of homeopathic medicines. As a world leader in the sector, the company specializes in the development and production of a wide range of homeopathic products. Its portfolio includes single medicines and popular specialty preparations, such as the Arnicare® line for pain relief and Oscillococcinum® for flu-like symptoms. With a history spanning over 100 years, Boiron distributes its products to consumers worldwide through various retail channels. The company's investor relations are managed under its Boiron Finances division.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BOIRON and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-18 17:45
Interim Report
RAPPORT FINANCIER SEMESTRIEL 2025
French 6.3 MB
2025-09-18 17:45
Earnings Release
CHIFFRE D'AFFAIRES ET RÉSULTATS DU PREMIER SEMESTRE 2025
French 635.6 KB
2025-06-10 17:45
Declaration of Voting Results & Voting Rights Announcements
Déclaration des droits de vote au 31 mai 2025
French 270.0 KB
2025-04-29 17:30
Pre-Annual General Meeting Information
Mise à disposition des documents préparatoires à l'Assemblée Générale mixte du …
French 242.2 KB
2025-04-22 16:00
Annual Report (ESEF)
Rapport financier annuel 2024
French 3.1 MB
2025-04-22 16:00
Report Publication Announcement
Mise à disposition du Rapport Financier Annuel 2024
French 142.3 KB
2025-04-22 15:00
Annual Report (ESEF)
Rapport Financier Annuel 2024
French 3.1 MB
2025-04-10 17:40
Declaration of Voting Results & Voting Rights Announcements
Déclaration des droits de vote au 31 mars 2025
French 158.9 KB
2025-04-03 17:45
Earnings Release
CHIFFRE D'AFFAIRES ET RÉSULTATS 2024
French 676.6 KB
2025-03-13 16:25
Declaration of Voting Results & Voting Rights Announcements
Déclaration des droits de vote au 28 février 2025
French 269.2 KB
2025-01-14 15:00
Declaration of Voting Results & Voting Rights Announcements
Déclaration des droits de vote au 31 décembre 2024
French 158.7 KB
2025-01-14 10:30
Share Issue/Capital Change
ÉLIGIBILITÉ DES TITRES BOIRON AU PEA-PME
French 361.7 KB
2024-12-12 09:45
Board/Management Information
Les Laboratoires BOIRON annoncent la nomination de ascal Houdayer au poste de D…
French 225.4 KB
2024-12-11 10:20
Declaration of Voting Results & Voting Rights Announcements
Déclaration des droits de vote au 30 novembre 2024
French 158.9 KB
2024-11-21 17:45
Business and Financial Review
COMMUNIQUÉ DE PRESSE
French 294.0 KB

Automate Your Workflow. Get a real-time feed of all BOIRON filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BOIRON via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-10-20 N/A Other Sell 858,660 34,037,282.40 EUR
2023-10-20 N/A Other Sell 462,964 18,351,892.96 EUR
2023-10-20 N/A Other Sell 272,184 10,789,373.76 EUR
2023-10-20 N/A Other Sell 198,664 7,875,040.96 EUR
2023-10-20 N/A Other Sell 5,900 233,876.00 EUR
2023-10-20 N/A Other Sell 4,748 188,210.72 EUR
2023-10-20 N/A Other Sell 2,978 118,047.92 EUR

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC

Talk to a Data Expert

Have a question? We'll get back to you promptly.